Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Microbiome Diagnostics Market, by Application
1.4.2 Europe Microbiome Diagnostics Market, by Product
1.4.3 Europe Microbiome Diagnostics Market, by Sample
1.4.4 Europe Microbiome Diagnostics Market, by Technology
1.4.5 Europe Microbiome Diagnostics Market, by End User
1.4.6 Europe Microbiome Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Microbiome Diagnostics Market
Chapter 5. Europe Microbiome Diagnostics Market by Application
5.1 Europe Disease Diagnostics Market by Country
5.2 Europe Microbiome Diagnostics Market by Disease Diagnostics Type
5.2.1 Europe Gastrointestinal Disorders Market by Country
5.2.2 Europe Metabolic Diseases Market by Country
5.2.3 Europe Others Market by Country
5.3 Europe Research Application Market by Country
Chapter 6. Europe Microbiome Diagnostics Market by Product
6.1 Europe Reagents & Kits Market by Country
6.2 Europe Instruments Market by Country
Chapter 7. Europe Microbiome Diagnostics Market by Sample
7.1 Europe Fecal Market by Country
7.2 Europe Saliva Market by Country
7.3 Europe Skin Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Microbiome Diagnostics Market by Technology
8.1 Europe 16S rRNA Sequencing Market by Country
8.2 Europe Shot Gun Metagenomics Market by Country
8.3 Europe Metatranscriptomics Market by Country
8.4 Europe Others Market by Country
Chapter 9. Europe Microbiome Diagnostics Market by End User
9.1 Europe Hospitals Market by Country
9.2 Europe Academic & Research Institutes Market by Country
9.3 Europe Biotechnology & Pharmaceutical Companies Market by Country
Chapter 10. Europe Microbiome Diagnostics Market by Country
10.1 Germany Microbiome Diagnostics Market
10.1.1 Germany Microbiome Diagnostics Market by Application
10.1.1.1 Germany Microbiome Diagnostics Market by Disease Diagnostics Type
10.1.2 Germany Microbiome Diagnostics Market by Product
10.1.3 Germany Microbiome Diagnostics Market by Sample
10.1.4 Germany Microbiome Diagnostics Market by Technology
10.1.5 Germany Microbiome Diagnostics Market by End User
10.2 UK Microbiome Diagnostics Market
10.2.1 UK Microbiome Diagnostics Market by Application
10.2.1.1 UK Microbiome Diagnostics Market by Disease Diagnostics Type
10.2.2 UK Microbiome Diagnostics Market by Product
10.2.3 UK Microbiome Diagnostics Market by Sample
10.2.4 UK Microbiome Diagnostics Market by Technology
10.2.5 UK Microbiome Diagnostics Market by End User
10.3 France Microbiome Diagnostics Market
10.3.1 France Microbiome Diagnostics Market by Application
10.3.1.1 France Microbiome Diagnostics Market by Disease Diagnostics Type
10.3.2 France Microbiome Diagnostics Market by Product
10.3.3 France Microbiome Diagnostics Market by Sample
10.3.4 France Microbiome Diagnostics Market by Technology
10.3.5 France Microbiome Diagnostics Market by End User
10.4 Russia Microbiome Diagnostics Market
10.4.1 Russia Microbiome Diagnostics Market by Application
10.4.1.1 Russia Microbiome Diagnostics Market by Disease Diagnostics Type
10.4.2 Russia Microbiome Diagnostics Market by Product
10.4.3 Russia Microbiome Diagnostics Market by Sample
10.4.4 Russia Microbiome Diagnostics Market by Technology
10.4.5 Russia Microbiome Diagnostics Market by End User
10.5 Spain Microbiome Diagnostics Market
10.5.1 Spain Microbiome Diagnostics Market by Application
10.5.1.1 Spain Microbiome Diagnostics Market by Disease Diagnostics Type
10.5.2 Spain Microbiome Diagnostics Market by Product
10.5.3 Spain Microbiome Diagnostics Market by Sample
10.5.4 Spain Microbiome Diagnostics Market by Technology
10.5.5 Spain Microbiome Diagnostics Market by End User
10.6 Italy Microbiome Diagnostics Market
10.6.1 Italy Microbiome Diagnostics Market by Application
10.6.1.1 Italy Microbiome Diagnostics Market by Disease Diagnostics Type
10.6.2 Italy Microbiome Diagnostics Market by Product
10.6.3 Italy Microbiome Diagnostics Market by Sample
10.6.4 Italy Microbiome Diagnostics Market by Technology
10.6.5 Italy Microbiome Diagnostics Market by End User
10.7 Rest of Europe Microbiome Diagnostics Market
10.7.1 Rest of Europe Microbiome Diagnostics Market by Application
10.7.1.1 Rest of Europe Microbiome Diagnostics Market by Disease Diagnostics Type
10.7.2 Rest of Europe Microbiome Diagnostics Market by Product
10.7.3 Rest of Europe Microbiome Diagnostics Market by Sample
10.7.4 Rest of Europe Microbiome Diagnostics Market by Technology
10.7.5 Rest of Europe Microbiome Diagnostics Market by End User
Chapter 11. Company Profiles
11.1 Illumina, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expense
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.6 SWOT Analysis
11.2 Becton, Dickinson, and Company
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Product Launches and Product Expansions:
11.2.5.2 Trails and Approvals:
11.2.6 SWOT Analysis
11.3 Genetic Analysis AS
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Regional Analysis
11.3.4 Recent strategies and developments:
11.3.4.1 Partnerships, Collaborations, and Agreements:
11.4 Microba Life Sciences Limited
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Partnerships, Collaborations, and Agreements:
11.4.5.2 Product Launches and Product Expansions:
11.5 BioMe Oxford Ltd
11.5.1 Company Overview
11.5.2 Recent strategies and developments:
11.5.2.1 Partnerships, Collaborations, and Agreements:
11.6 Viome Life Sciences, Inc.
11.6.1 Company Overview
11.6.2 Recent strategies and developments:
11.6.2.1 Product Launches and Product Expansions:
11.6.2.2 Acquisition and Mergers:
11.7 GoodGut S.L.U. (HIPRA, S.A.)
11.7.1 Company Overview
11.8 Sun Genomics
11.8.1 Company Overview
11.9 Origin Sciences Limited
11.9.1 Company Overview
11.10. Decode Age
11.10.1 Company Overview
Unique Offerings 